Can heparin‐induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal
- 1 July 2008
- journal article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 6 (7), 1243-1246
- https://doi.org/10.1111/j.1538-7836.2008.02972.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A Spontaneous Prothrombotic Disorder Resembling Heparin-induced ThrombocytopeniaAmerican Journal Of Medicine, 2008
- Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)Thrombosis and Haemostasis, 2008
- Fondaparinux for the treatment of patients with acute heparininduced thrombocytopeniaThrombosis and Haemostasis, 2008
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxNew England Journal of Medicine, 2007
- Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparinBlood, 2005
- IN FOCUS: Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparinJournal of Thrombosis and Haemostasis, 2005
- Heparin-Induced Thrombocytopenia: Recognition, Treatment, and PreventionChest, 2004
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Pentosan polysulfate‐induced thrombocytopenia and thrombosisAmerican Journal of Hematology, 1994
- Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycanBritish Journal of Haematology, 1992